Research velocity is the new competitive edge in pharma and biotech. Whether it’s deprioritizing therapeutic targets, dropping drug candidates mid-development, the ability to reach high-stakes decisions faster is what sets leaders apart.
But speed doesn’t come from investment alone—it demands infrastructure that keeps up. In 2025, R&D is still held back by fragmented tools, slow compute, and siloed workflows—delaying decisions, wasting resources, and shifting focus from science to system upkeep.
In this on-demand webinar, Evan Floden, CEO and Co-founder of Seqera, outlines a leadership framework for modern R&D infrastructure—enabling faster decisions, stronger collaboration, and greater real-world impact.